Friday Night Wiki
TopicsTagsAbout
Buy me a coffee
Biology and Biotech Fundamentals Tutorial

Introduction: What Biology and Biotech Are

This chapter sets up what biology and biotech each mean, why the two are converging, and what literacy in this field actually buys you.

Biology

Biology is the study of living things. That sentence is boring and correct. It covers everything from the biochemistry inside a single bacterium to the ecology of a rainforest to the way memory works in a human brain.

Modern biology is unified by a few big ideas:

  • Every living thing is made of cells
  • Cells run on a common set of molecules (DNA, RNA, proteins, lipids, sugars)
  • All life on Earth shares ancestry: bacteria, plants, and humans are distant cousins
  • The theory that explains this diversity is evolution by natural selection

These are not philosophical positions. They are the working assumptions of the field, and every working biologist uses them daily. Chapter 7 revisits evolution; most of the rest of the tutorial assumes it quietly.

Biotech

Biotech is using biology as technology. The word is broad:

  • Brewing beer is biotech (you use yeast to convert sugar into alcohol)
  • Insulin from engineered bacteria is biotech
  • A CRISPR treatment for sickle-cell disease is biotech
  • Lab-grown meat is biotech
  • DNA-based data storage is biotech

Any time humans deliberately use living systems, or parts of them, to make or do something, you're in biotech territory.

In practice, when people say "biotech" today, they usually mean the cluster of companies and tools built around molecular biology since the 1970s: recombinant DNA, monoclonal antibodies, PCR, sequencing, CRISPR, mRNA, cell therapy, gene therapy, synthetic biology. This tutorial focuses on that cluster.

A Short Timeline

Enough history to set context without dwelling:

1865    Mendel publishes genetics of pea plants (ignored for 35 years)
1953    Watson, Crick, Franklin, Wilkins solve the DNA double helix
1973    Cohen and Boyer invent recombinant DNA; biotech industry begins
1976    Genentech founded; first biotech company
1982    Human insulin from engineered bacteria approved
1983    PCR invented (Kary Mullis)
1990    Human Genome Project starts
2003    Human genome "complete" (at a cost of ~$3 billion)
2012    CRISPR-Cas9 adapted for genome editing (Doudna, Charpentier)
2020    mRNA vaccines (Moderna, BioNTech) enter widespread use
2023    AlphaFold 3 solves protein structure prediction for most proteins
2025+   Cell therapies, gene therapies, programmed cells as drugs

Two things worth noticing. First, the technical acceleration: cost of sequencing dropped ten-thousand-fold in twenty years. Second, the compounding: each tool made the next one possible. Recombinant DNA made insulin production possible; sequencing made targets identifiable; CRISPR made editing accessible.

Why Now

Four converging reasons biology matters to readers in 2026:

1. Sequencing is cheap

Reading an entire human genome cost around $3 billion in 2003. Today it's under $500. This changes the field: every disease study now includes genomics, every drug program can profile patients genetically, every biotech company generates more data than they know what to do with.

2. Editing is accessible

CRISPR made it possible, in one experiment, to knock out a gene in a cell line. Before CRISPR, this was possible but painful: zinc finger nucleases and TALENs required expert design and months of work. Now it's a graduate-student protocol.

3. AI is eating biology

AlphaFold reshaped protein structure prediction. Large language models trained on protein sequences (ESM, RFdiffusion) are designing novel proteins. Drug discovery is being re-tooled around AI-guided design. None of this makes humans irrelevant; all of it shifts where the bottleneck is.

4. Manufacturing is opening up

Biotech used to mean pharma. Now it means a startup in a shared-lab space making enzymes, or a team engineering yeast to produce human milk proteins, or a lab designing probiotic strains to secrete specific therapies. Cheap tools mean more players.

What Biotech Is Not

A short list of clarifications:

  • Biotech is not inherently good or bad. Like any technology, it amplifies whatever intent uses it. GMO crops have improved nutrition and caused ecological disruption; CRISPR has cured genetic diseases and raised serious ethical questions
  • Biotech is not a single industry. Pharma, agricultural biotech, industrial biotech, DTC genetic testing, synthetic biology tools companies are all "biotech" and behave very differently
  • Biotech is not the same as biology. A biologist studies cells; a biotech engineer uses them. Overlap is enormous; they are not identical fields
  • Biotech is not all hype. It is not all real progress either. Sorting is part of the skill this tutorial tries to teach

Why Non-Biologists Should Care

A few practical reasons:

  • You'll read biotech news better. "Company X's CRISPR therapy shows promise" becomes a sentence you can evaluate rather than a headline you pattern-match to "good"
  • You'll invest, hire, or vote more carefully. Biotech policy and biotech investment depend on lay understanding. Thin understanding produces bad outcomes in both
  • You'll get more out of medicine. Most adults will at some point receive a drug, a vaccine, or a diagnostic test whose logic comes from this field. Understanding the logic makes you a more informed patient
  • It's interesting. Biology is one of the most interesting things there is. You were made of cells; cells are bizarre. That's reason enough

The Analogy Problem

Biology adopts computer analogies. DNA is "code". Cells "run programs". Genes are "modules". Proteins are "machines".

These are useful starting points and misleading endpoints. Real cells are noisy, stochastic, context-dependent, and full of workarounds. A cell is less like a well-written program and more like a legacy codebase where random modules sometimes take different paths on Tuesday.

When you read biotech explanations, be alert to where the computer metaphor breaks down. It usually breaks down at the interesting points.

How to Use This Tutorial

  • Read in order. Gene editing is incomprehensible without the central dogma; drug development is hollow without knowing what a target is
  • Don't memorise vocabulary aggressively. You'll pick up the words through context. The concepts matter more than the terms
  • Cross-reference. Some chapters build on earlier ones; re-read if a concept lands hazily
  • Stay curious about biology, not just biotech. The field is most interesting when you're interested in the living systems, not just the applications

What You'll Have at the End

Not the ability to run a lab. Not drug development expertise. Not the right to use the word "CRISPR" in academic papers.

What you'll have:

  • Working vocabulary for the molecular biology you read about
  • A mental model of how life is organised, from atoms to cells to organisms
  • Enough grounding to read biotech news with some discrimination
  • The map to go deeper in any sub-area you want to pursue

That's a real amount of literacy. Useful in its own right; a starting point if you want to go further.

Common Pitfalls Already

"Biology is all memorisation." High-school biology can feel that way. Real biology is much more about understanding a few core mechanisms and seeing them recur in different contexts. If you're memorising, you're doing it wrong

"Biotech is just like software." It shares features but breaks in ways software doesn't. Time scales are longer. Iteration is slower. The "bugs" are wet and sometimes alive. The economics are different

"CRISPR changed everything." It changed a lot. It didn't change everything. Biology is still mostly hard. CRISPR shifted what's possible in labs; many translation problems it doesn't touch

"I'm not a scientist, so I can't engage with this." You can engage with it to whatever depth you want. Professional science has high barriers; literacy doesn't

Next Steps

Continue to 02-cells.md for the basic unit everything else is built on.